Harbor:Sepsis antibiotics: Difference between revisions

(Text replacement - "0 mg" to "0mg")
Line 35: Line 35:
*'''Hospitalized ward patients (PORT III):'''  
*'''Hospitalized ward patients (PORT III):'''  
**[[Beta-lactam]] + [[macrolide]] OR [[doxycycline]] ([[quinolone]] ok, but save for sick pt):  
**[[Beta-lactam]] + [[macrolide]] OR [[doxycycline]] ([[quinolone]] ok, but save for sick pt):  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500 mg IV Qday OR '''[[Doxycycline]] '''100mg IV BID  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500mg IV Qday OR '''[[Doxycycline]] '''100mg IV BID  
***If cephalosporin allergy:  
***If cephalosporin allergy:  
****'''[[Moxifloxacin]] '''400 mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
****'''[[Moxifloxacin]] '''400mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
*'''PCU/ICU patients with out RF for [[Pseudomonas]] or [[MRSA]]:'''  
*'''PCU/ICU patients with out RF for [[Pseudomonas]] or [[MRSA]]:'''  
**[[Beta-lactam]] + [[macrolide]] OR [[Quinolone]] (Save for sick patients if possible). [[Quinolone]] monotheraphy not acceptable for these patients:  
**[[Beta-lactam]] + [[macrolide]] OR [[Quinolone]] (Save for sick patients if possible). [[Quinolone]] monotheraphy not acceptable for these patients:  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500 mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
***'''[[Ceftriaxone]] '''1 gm IV Qday + '''[[Azithromycin]] '''500mg IV Qday OR '''[[Levofloxacin]] '''750mg IV Qday  
*'''PCU/ICU patients w/RF for [[Pseudomonas]]:'''  
*'''PCU/ICU patients w/RF for [[Pseudomonas]]:'''  
**'''[[Cefepime]] '''2g IV Q8H + '''[[Levofloxacin]] '''750mg IV Qday
**'''[[Cefepime]] '''2g IV Q8H + '''[[Levofloxacin]] '''750mg IV Qday
Line 55: Line 55:
***Add '''[[Meropenem]]'''  
***Add '''[[Meropenem]]'''  
*[[Cephalosporin]] allergy:  
*[[Cephalosporin]] allergy:  
**[[Clinda]] 600 mg IV  
**[[Clinda]] 600mg IV  
**[[Cipro]] 400 mg IV  
**[[Cipro]] 400mg IV  
**[[Gentamicin]] 5-7 mg/kg IV
**[[Gentamicin]] 5-7 mg/kg IV


Line 69: Line 69:
**[[Metronidazole]] 1.5 mg IV
**[[Metronidazole]] 1.5 mg IV
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Cipro]] 400 mg IV
**[[Cipro]] 400mg IV
**[[Metronidazole]] 1.5 g IV
**[[Metronidazole]] 1.5 g IV
**[[Gentamicin]] 5-7 mg/kg IV
**[[Gentamicin]] 5-7 mg/kg IV
Line 83: Line 83:
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Vancomycin]] 1g IV
**[[Vancomycin]] 1g IV
**[[Cipro]] 400 mg IV
**[[Cipro]] 400mg IV
**[[Gentamicin]] 5 mg/kg IV
**[[Gentamicin]] 5 mg/kg IV


Line 120: Line 120:
**[[Vancomycin]] 1 gm IV
**[[Vancomycin]] 1 gm IV
**[[Ceftriaxone]] 1 gm IV
**[[Ceftriaxone]] 1 gm IV
**[[Clinda]] 600 mg IV
**[[Clinda]] 600mg IV
**Consider: Gent 5-7mg/k IV
**Consider: Gent 5-7mg/k IV
*Healthcare Assoc.           
*Healthcare Assoc.           
Line 128: Line 128:
*Cephalosporin allergy           
*Cephalosporin allergy           
**[[Vancomycin]] 1 gm IV
**[[Vancomycin]] 1 gm IV
**[[Clinda]] 600 mg IV
**[[Clinda]] 600mg IV
**[[Cipro]] 400 mg IV
**[[Cipro]] 400mg IV
**[[Gentamicin]] 5-7mg/kg
**[[Gentamicin]] 5-7mg/kg



Revision as of 01:17, 19 July 2016

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

Healthcare Associated PNA (HCAP) + Hospital Associated PNA (HAP)

HAP occurs if patient develops PNA 2-3 days after hospitalization. HCAP occus in non-hospitalized patient with extensive healthcare contact.

Abdominal/Pelvic

Urosepsis

Meningitis (Nl/Community)

Meningitis (Nl/Post neurosurgical)

Meningitis (Immunocomp)

(Cirrhosis, EtoH, age > 65, steroids, HIV)

Necrotizing Soft-tissue Infection

Neutropenic Fever

  • Severe Sepsis
    • Cefepime 2 g IVPB x 1
    • Vancomycin 1 g IVPB x 1
  • Septic Shock

See Also

Harbor:Antibiotics by diagnosis

See also Harbor: Sepsis core measures
Initial Antibiotics in Sepsis (Main)

References

  1. Form v2011.09.15